Free Alerts   Login
Consumer Staples › Retail-Drug Stores And Proprietary Stores

WBA Stock Price Correlated With Walgreens Boots Alliance Financials

WBA Stock Price vs. Quarterly
WBA
Income Statement
Cash Flow
Balance Sheet

WBA Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

WBA Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

WBA Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Insider Trading

 
Change
Value
Transaction
SEC Form 4
JARRETT VALERIE B   Director
4,456 sh at $22
$99,993
Buy
WENTWORTH TIMOTHY C   Chief Executive Officer
10,000 sh at $24
$242,220
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Vanguard Group
83,140,103 sh
-3,535,095 sh
-4%
$2,170,787
$243,132
Blackrock.
65,894,048 sh
-140,448 sh
0%
$1,720,495
$251,888
State Street
54,179,343 sh
-57,361 sh
0%
$1,414,623
$208,399
Invesco.
19,052,399 sh
2,025,979 sh
12%
$497,458
$118,791
Capital World Investors
18,448,648 sh
4,163,317 sh
29%
$481,694
$163,988
Morgan Stanley
16,957,000 sh
4,372,629 sh
35%
$442,745
$162,867
Geode Capital Management
16,560,044 sh
416,631 sh
3%
$431,282
$73,008
Proshare Advisors
8,319,515 sh
1,378,279 sh
20%
$217,223
$62,850
Northernrp
7,371,955 sh
-331,448 sh
-4%
$192,482
$21,158
Legal & General Group Plc
7,356,393 sh
710,807 sh
11%
$192,076
$44,278
Camber Capital Management Lp
7,000,000 sh
1,800,000 sh
35%
$182,770
$67,122
Charles Schwab Investment Management
6,519,845 sh
613,847 sh
10%
$170,233
$38,884
Susquehanna International Group,
Call options for 6,495,600 sh
6,495,600 sh
NEW
$169,599
$169,599
Bank Of New York Mellon
5,951,607 sh
-463,936 sh
-7%
$155,397
$12,716
UBS Asset Management Americas
5,568,103 sh
507,316 sh
10%
$145,384
$32,832
Goldman Sachs Group
4,628,311 sh
4,598,311 sh
15328%
$120,845
$120,178
Lsv Asset Management
4,511,857 sh
-207,726 sh
-4%
$118
$13
Capital Fund Management S.A.
Call options for 4,135,700 sh
2,430,400 sh
143%
$107,983
$70,057
Allianz Asset Management Gmbh
3,918,066 sh
631,630 sh
19%
$102,301
$29,210
Sessa Capital Im,
3,774,208 sh
3,774,208 sh
NEW
$98,545
$98,545
COMPANY PROFILE
Note 1.  Organization

Walgreens Boots Alliance, Inc. (“Walgreens Boots Alliance”) and subsidiaries are a global pharmacy-led wellbeing enterprise. Its operations are conducted through three reportable segments (Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale). See Note 19, Segment Reporting for additional discussion.

On December 31, 2014, Walgreens Boots Alliance became the successor of Walgreen Co. (“Walgreens”) pursuant to a merger designed to effect a reorganization of Walgreens into a holding company structure (the “Reorganization”). Pursuant to the Reorganization, Walgreens became a wholly-owned subsidiary of Walgreens Boots Alliance, a newly-formed Delaware corporation, and each issued and outstanding share of Walgreens common stock, par value $0.078125, converted on a one-to-one basis into Walgreens Boots Alliance common stock, par value $0.01.

On December 31, 2014, following the completion of the Reorganization, Walgreens Boots Alliance completed the acquisition of the remaining 55% of Alliance Boots GmbH (“Alliance Boots”) that Walgreens did not previously own (the “Second Step Transaction”) in exchange for £3.133 billion in cash and approximately 144.3 million shares of Walgreens Boots Alliance common stock pursuant to the Purchase and Option Agreement dated June 18, 2012, as amended (the “Purchase and Option Agreement”). Alliance Boots became a consolidated subsidiary and ceased being accounted for under the equity method immediately upon completion of the Second Step Transaction. For financial reporting and accounting purposes, Walgreens Boots Alliance was the acquirer of Alliance Boots. The consolidated financial statements (and other data) reflect the results of operations and financial position of Walgreens and its subsidiaries for periods prior to December 31, 2014 and of Walgreens Boots Alliance and its subsidiaries for periods from and after the effective time of the Reorganization on December 31, 2014.

References to the “Company” refer to Walgreens Boots Alliance and its subsidiaries from and after the effective time of the Reorganization on December 31, 2014 and, prior to that time, to the predecessor registrant Walgreens and its subsidiaries, except as otherwise indicated or the context otherwise requires.

Free historical financial statements for Walgreens Boots Alliance Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 36 quarters since 2015. Compare with WBA stock chart to see long term trends.

Data imported from Walgreens Boots Alliance Inc. SEC filings. Check original filings before making any investment decision.